216 related articles for article (PubMed ID: 20209503)
1. Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.
Lee SH; Biron CA
Eur J Immunol; 2010 Apr; 40(4):923-32. PubMed ID: 20209503
[TBL] [Abstract][Full Text] [Related]
2. Viral Evasion of Natural Killer Cell Activation.
Ma Y; Li X; Kuang E
Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell specificity for viral infections.
Hammer Q; Rückert T; Romagnani C
Nat Immunol; 2018 Aug; 19(8):800-808. PubMed ID: 30026479
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells in antiviral defense: function and regulation by innate cytokines.
Biron CA; Nguyen KB; Pien GC; Cousens LP; Salazar-Mather TP
Annu Rev Immunol; 1999; 17():189-220. PubMed ID: 10358757
[TBL] [Abstract][Full Text] [Related]
5. The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?
Miletić A; Krmpotić A; Jonjić S
Eur J Immunol; 2013 Apr; 43(4):867-77. PubMed ID: 23440773
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells: fighting viruses and much more.
Colonna M; Jonjic S; Watzl C
Nat Immunol; 2011 Feb; 12(2):107-10. PubMed ID: 21245897
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into activation of antiviral NK cell responses.
Finton KA; Strong RK
Immunol Rev; 2012 Nov; 250(1):239-57. PubMed ID: 23046134
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience.
Vidal SM; Khakoo SI; Biron CA
Curr Opin Virol; 2011 Dec; 1(6):497-512. PubMed ID: 22180766
[TBL] [Abstract][Full Text] [Related]
9. NK cells in host responses to viral infections.
Lam VC; Lanier LL
Curr Opin Immunol; 2017 Feb; 44():43-51. PubMed ID: 27984782
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell Memory.
O'Sullivan TE; Sun JC; Lanier LL
Immunity; 2015 Oct; 43(4):634-45. PubMed ID: 26488815
[TBL] [Abstract][Full Text] [Related]
11. Immune evasion of natural killer cells by viruses.
Jonjić S; Babić M; Polić B; Krmpotić A
Curr Opin Immunol; 2008 Feb; 20(1):30-8. PubMed ID: 18206359
[TBL] [Abstract][Full Text] [Related]
12. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
13. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
[TBL] [Abstract][Full Text] [Related]
14. NK cells and their receptors during viral infections.
Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Parolini S; Moretta A; Sivori S
Immunotherapy; 2011 Sep; 3(9):1075-86. PubMed ID: 21913830
[TBL] [Abstract][Full Text] [Related]
15. How to trigger a killer: modulation of natural killer cell reactivity on many levels.
Watzl C
Adv Immunol; 2014; 124():137-70. PubMed ID: 25175775
[TBL] [Abstract][Full Text] [Related]
16. NK cell subsets and their role in allergy.
Deniz G; Akdis M
Expert Opin Biol Ther; 2011 Jul; 11(7):833-41. PubMed ID: 21426239
[TBL] [Abstract][Full Text] [Related]
17. Activation of natural killer cells: underlying molecular mechanisms revealed.
Backström E; Kristensson K; Ljunggren HG
Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
[TBL] [Abstract][Full Text] [Related]
18. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
Koch J; Steinle A; Watzl C; Mandelboim O
Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
[TBL] [Abstract][Full Text] [Related]
19. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
